Skip to main content
. Author manuscript; available in PMC: 2022 Jan 15.
Published in final edited form as: J Immunol. 2020 Dec 4;206(2):329–334. doi: 10.4049/jimmunol.2001025

Figure 3. Human PBMCs from COVID-19 patients are enriched for ALOX5 expressing cells and express higher levels of ALOX5.

Figure 3.

(A) UMAP dimensionality reduction plot of a published human PBMC single-cell RNA Seq dataset (21) identifying twenty cell types. (B) UMAP depicting ALOX5 expressing cells in blue. (C) Violin plots indicating ALOX5 expression levels within specific cellular populations in healthy (blue) or COVID (red) PBMCs. Statistical significance was determined by a Mann-Whitney test; * p < 0.05. ** p< 0.01.